Amar Jesani, S Srinivasan, Sarojini N, Vaibhao Ambhore, Veena Johari | Economic and Political Weekly | Vol 50, Issue 14 | 4 April 2015
This article provides a detailed critique of the formulae to provide compensation to subjects of clinical trials who may suffer serious adverse effects during their participation. The present formulae used by the Central Drugs Standard Control Organization display a lack of medical ethics and disregard the accepted norms.
